Late-Breaking Studies Affecting Patient Outcomes II

Late Breaker Moderator(s)

• EG

  Emma Grainger, PhD

  Editor
  Elsevier
  London, United Kingdom
• RT

  Ravi Thiagarajan, MBBS

  Cardiac Intensivist
  Boston Children's Hospital
  Boston, Massachusetts, United States

This session features late-breaking literature from leading medical journals.

Congress features sessions on a record-breaking number of new journal articles, guidelines, and research from SCCM and other leading medical journals. Find details here.

Presentations:

• Timely Cessation of Proton Pump Inhibitors in Critically Ill Patients Impacts Morbidity and Mortality: A Propensity Score Matched Cohort Study (CCM)
• Reducing Antibiotic Treatment Duration for Ventilator-Associated Pneumonia: A Multicenter, Individually Randomized, Open-Label, Non-Inferiority Trial (REGARD-VAP) (Lancet Respiratory Medicine)
• Methylprednisolone, IV Immunoglobulin, Tocilizumab, or Anakinra for Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS/MIS-C): Report From a Randomized, Controlled, Open-Label Platform Trial (Lancet Child and Adolescent Health)
• Resuscitation With Vitamin C, Hydrocortisone, and Thiamine in Children With Septic Shock: A Multicenter, Randomized Pilot Study and the Corresponding Observational Study of Serum Levels of Vitamin C and Thiamine in Children With Suspected Sepsis: A Prospective Observational Cohort Study (PCCM)